Search Within

David Solit

Formats
  1. Meeting Abstract (391)
  2. Journal Article (366)
  3. Editorial (9)
  4. Book Section (4)
  5. Research Letter (4)
  6. Review (4)
  7. Correspondence (2)
  8. Guidelines (2)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (783)
  2. GSK Faculty (783)
  3. Genitourinary Oncology Service (783)
  4. Human Oncology and Pathogenesis Program (783)
  5. Solid Tumor Oncology Division (783)
  6. Department of Pathology and Laboratory Medicine (510)

More Groups

People
  1. Michael Berger (317)
  2. Hikmat Al-Ahmadie (186)
  3. Gopakumar Iyer (184)
  4. Neal Rosen (155)
  5. Nikolaus Schultz (150)
  6. Dean Bajorin (130)

More People

Years
  1. 2025 (17)
  2. 2024 (38)
  3. 2023 (39)
  4. 2022 (44)
  5. 2021 (47)
  6. 2020 (59)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (99)
  3. Clinical Cancer Research (77)
  4. Laboratory Investigation (42)
  5. Modern Pathology (37)
  6. Cancer Discovery (24)

More Publications

Publishers
  1. American Association for Cancer Research (219)
  2. American Society of Clinical Oncology (181)
  3. Nature Publishing Group (97)
  4. Nature Research (39)
  5. Elsevier Inc. (31)
  6. Oxford University Press (29)

More Publishers

Results (783)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells
    Journal Article

    Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C. T.; Tang, L.; Song, L.; Zeng, Z.; Shah, M.; Christensen, J. G.; Rosen, N.; Solit, D. B.; more...
    Molecular Cancer Therapeutics (2008)

    Fulltext@MSK | Save
  • BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Pratilas, C. A.; Halilovic, E.; Sawai, A.; Grbovic-Huezo, O.; Rosen, N.; Solit, D. B.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of docetaxel and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Amodio, A. J.; Gignac, G. A.; Flatts, E.; Slovin, S.; Solit, D.; Rathkopf, D.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A physiologically-based pharmacokinetic (PBPK) and pharmacodynamic (PD) model of docetaxel (Doc) and neutropenia in humans
    Meeting Abstract

    Florian, J. A. Jr; Egorin, M. J.; Zamboni, W. C.; Eiseman, J. L.; Lagattuta, T. F.; Belani, C. P.; Chatta, G. S.; Scher, H. I.; Solit, D. B.; Parker, R. S.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Extracellular cleaved HER2 (p95) confers partial resistance to trastuzumab but not HSP90 inhibitors in models of HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Scaltriti, M.; Baselga, J.; Ye, Q.; Solit, D.; Norton, L.; Rosen, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The PI3K/AKT and MAPK signaling cooperate to mediate translational initiation and cell survival in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Zhen, W.; Solit, D.; Rosen, N.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Activating mutation in B-RAF disables normal feedback inhibition of MEK and results in increased output of the RAF/MEK/MAPK signaling pathway
    Meeting Abstract

    Pratilas, C. A.; Taylor, B.; Nelander, S.; Grbovic-Huezo, O.; Viale, A.; Solit, D.; Sander, C.; Rosen, N.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • BRAF mutation predicts for MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Halilovic, E.; Pratilas, C.; Sawai, A.; Grbovic, O.; Rosen, N.; Solit, D. B.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Targeting MEK in tumors with BRAF and RAS mutations
    Meeting Abstract

    Solit, D.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Pratilas, C. A.; Halilovic, E.; Persaud, Y.; Sawai, A.; Grbovic-Huezo, O.; Janakiraman, M.; Rosen, N.; Solit, D. B.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save